INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $10,000 | -61.5% | 367 | -60.0% | 0.00% | -60.0% |
Q2 2021 | $26,000 | +8.3% | 918 | +30.2% | 0.01% | 0.0% |
Q1 2021 | $24,000 | +9.1% | 705 | +8.5% | 0.01% | 0.0% |
Q4 2020 | $22,000 | -29.0% | 650 | -32.4% | 0.01% | -37.5% |
Q3 2020 | $31,000 | +6.9% | 962 | -8.3% | 0.01% | -20.0% |
Q2 2020 | $29,000 | +70.6% | 1,049 | 0.0% | 0.01% | +42.9% |
Q1 2020 | $17,000 | -34.6% | 1,049 | -4.4% | 0.01% | 0.0% |
Q4 2019 | $26,000 | +1200.0% | 1,097 | +915.7% | 0.01% | +600.0% |
Q3 2019 | $2,000 | – | 108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |